Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Yasue Obi"'
Autor:
Tatsuya Nakatani, Yasuro Kumeda, Shozo Yodoi, Harumi Nagayama, Kiyoshi Maekawa, Takayoshi Hamada, Shinya Nakatani, Hisako Fujii, Sosuke Kagitani, Minoru Yoshiyama, Yoshinori Sai, Ayumi Shintani, Yoshikazu Kato, Yoshihiro Tsujimoto, Tetsuo Shoji, Daijiro Kabata, Hisako Yoshida, Kenjiro Yamakawa, Mayumi Sakurai, Yoshiteru Ohno, Yasue Obi, Takayasu Matsumura, Kiyoshi Goto, Keiko Ota, Satoshi Sasaki, Masahito Imanishi, Shinichi Nishi, Shinichiro Ueda, Eiji Ishimura, Katsuhito Mori, Shigeichi Shoji, Masaaki Inaba, Kaori Shidara, Hideaki Yasuda, Masanori Emoto, K. Takahashi
Publikováno v:
Clin J Am Soc Nephrol
BACKGROUND AND OBJECTIVES: Vitamin D receptor activators and calcimimetics (calcium-sensing receptor agonists) are two major options for medical treatment of secondary hyperparathyroidism. A higher serum calcification propensity (a shorter T(50) valu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bf4e5f58cfdeff3d4ea07e93684bcc41
https://doi.org/10.2215/cjn.16601020
https://doi.org/10.2215/cjn.16601020
Autor:
Takayuki Hamano, Motoko Tanaka, Yoshitsugu Obi, Satoshi Yamaguchi, Tomoko Namba-Hamano, Naohisa Tomosugi, Yoshitaka Isaka, Akihiro Shimomura, Satoshi Mikami, Yoshiharu Tsubakihara, Akihito Kamoto, Yusuke Sakaguchi, Yasue Obi, Osamu Nishi
Publikováno v:
Scientific Reports, Vol 10, Iss 1, Pp 1-11 (2020)
Scientific Reports
Scientific Reports
In this multicentre double-blind randomized clinical trial, we investigated the effects of oral cholecalciferol supplementation on serum hepcidin and parameters related to anaemia and CKD-MBD among haemodialysis patients. Participants were assigned i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::41f80e2ce3cddce2d66953333b8629d2
https://doi.org/10.1038/s41598-020-72385-w
https://doi.org/10.1038/s41598-020-72385-w
Autor:
Takayuki Hamano, Yoshitaka Isaka, Nobuhiro Hashimoto, Yasue Obi, Daisuke Mori, Yusuke Sakaguchi, Tatsufumi Oka, Ayumi Matsumoto, Isao Matsui, Keiichi Kubota, Satoshi Yamaguchi
Publikováno v:
Clinical Journal of the American Society of Nephrology. 13:274-281
Background and objectives Circulating levels of anions that bind to magnesium and calcium are often altered in patients with CKD. However, it is unknown how these alterations affect the ionized fraction of magnesium and calcium. Design, setting, part
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5fe1d14bc7bd783aa444fb68f391da65
https://doi.org/10.2215/cjn.07930717
https://doi.org/10.2215/cjn.07930717
Autor:
Hiromi Rakugi, Yoshitaka Isaka, Satoshi Mikami, Akihiro Shimomura, Toru Inoue, Yoshitsugu Obi, Hirotaka Tanaka, Takayuki Hamano, Yasue Obi
Publikováno v:
Journal of Renal Nutrition. 26:380-390
Objective Vitamin B6 deficiency is common in hemodialysis patients and may contribute to anemia and abnormal bone metabolism in this population. Design 6-month, open-label, randomized controlled parallel-group study in hemodialysis centers. Subjects
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f7f4f259f21d7595e2766cb9019b68e0
https://doi.org/10.1053/j.jrn.2016.06.004
https://doi.org/10.1053/j.jrn.2016.06.004
Autor:
Kiichiro Sekiya, Kiyoshi Nakatsuka, Hidetaka Kawakami, Takami Miki, Yoshiki Nishizawa, Yasue Obi, Hirotoshi Morii, Masakazu Miura, Yoshiko Hirota
Publikováno v:
Journal of Bone and Mineral Metabolism. 15:153-159
Urinary excretion of pyridinium cross-links is one of the biochemical markers for bone resorption in metabolic bone diseases. Efficacy of immunoassay for deoxypyridinoline (D-pyr) for monitoring effects of antiresorptive therapy was evaluated in 44 w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c5f36631b0dab6ac713ff4188102c864
https://doi.org/10.1007/bf02489948
https://doi.org/10.1007/bf02489948
Autor:
Takayuki, Hamano, Naohiko, Fujii, Takahito, Ito, Enyu, Imai, Satoshi, Mikami, Masaya, Katayama, Yasue, Obi
Publikováno v:
Clinical calcium. 15
We studied the short-time effects of low dose estradiol (E2) on bone metabolism in hemodialysis (HD) patients. We prescribed transdermal E2 (0.36 mg every other day) to 17 non-diabetic postmenopausal osteoporotic HD patients and measured intact parat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::c26b6ac5f8c75294ba78198610535fbb
https://pubmed.ncbi.nlm.nih.gov/16279020
https://pubmed.ncbi.nlm.nih.gov/16279020